Read our latest advice on Coronavirus (COVID-19)

Our services are open and safe to attend – we are still here to help

Streetly, Matthew - consultant haematologist


Consultant profiles

Matthew Streetly, consultant haematologist


Tel: 020 7188 2900

Area of expertise: myeloma and plasma cell disorders


  • Biography

    Matthew Streetly, B.Med.Sci, BM, BS; MRCP(UK), FRCPath, PhD, has been a consultant at our hospital since 2008. He is the clinical lead for myeloma/plasma cell disorders and a member of the haemato-oncology inpatient attending team looking after inpatients with myeloma, lymphoma and leukaemia.

    Matthew has a special interest in the use of novel therapies for patients with myeloma and is the principal investigator on multiple clinical trials.

    Matthew is a member of the UK myeloma forum guidelines writing group and a special trustee of the British Society of Haematology. He has published widely on myeloma and related disorders and is an invited speaker at national and international meetings.

  • Education and training

    • Undergraduate training – University of Nottingham
    • Postgraduate haematology training – Guy's and St Thomas’
    • PhD investigating novel compounds in myeloma / myeloma apoptosis – Queen Mary, University of London
  • Specialist interests

    • Myeloma and other plasma cell disorders (Amyloidosis, MGUS)
    • Stem cell transplant
    • Lymphoma
  • Research interests

    • Clinical trials for novel therapies for myeloma
    • Myeloma diagnostics and biomarkers